The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On February 11, 2025, the Food and Drug Administration approved brentuximab vedotin (Adcetris ...
“The TALAPRO-2 study showed a significant improvement in overall survival in men with mCRPC treated with the combination of talazoparib and enzalutamide whether they had HRR gene alterations. In this ...
ALEXANDRIA, Va. – Nine studies exploring new approaches for the treatment of genitourinary cancers will be presented at the upcoming 2025 American Society of Clinical Oncology (ASCO) Genitourinary ...
The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...
Development and validation of a prognostic score for overall survival integrating baseline metabolically active tumor volume measured by 18 F-FDG PET/CT and clinical factors for metastatic colorectal ...
The Resilience Skills Training Program aims to improve physician wellness in oncology through a proactive approach. The program targets current trainees to help create a culture change surrounding ...
Over the last 50 years, research funded by the National Institutes of Health (NIH) and National Cancer Institute (NCI) has played a role in every major advancement related to cancer prevention, ...
Recruiting and developing oncology practice staff takes care and strategy. ASCO can be a unique resource as you search for ideal candidates and work to bolster the expertise and efficiency of your ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback